| DC4 Crosslinker |
DC4 Crosslinker |
1374647-94-5 |
| YH239-EE |
[N/A] |
1364488-67-4 |
| N-(3-Methylthiophene-2-carboxylic acid)-N′-[(3-hydroxy-2-naphthalenyl)methylene]hydrazide |
N-(3-Methylthiophene-2-carboxylic acid)-N′-[(3-hydroxy-2-naphthalenyl)methylene]hydrazide |
1364915-48-9 |
| 2-Fluoro-4'-[[4-(4-pyridinylMethyl)-1-piperazinyl]Methyl]-α,α-bis(trifluoroMethyl)-[1,1'-biphenyl]-4-Methanol |
化合物 T16929 |
1359164-11-6 |
| CEP-33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1346168-57-7 |
| CYM50308 |
CYM50308 |
1345858-76-5 |
| BAX INHIBITOR PEPTIDE, NEGATIVE CONTROL |
BAX INHIBITOR PEPTIDE, NEGATIVE CONTROL |
1315378-74-5 |
| PEP2-SVKE |
PEP2-SVKE |
1315378-76-7 |
| VU 0360223 |
VU 0360223 |
1274859-33-4 |
| YLF-466D |
3-[[(3E)-3-[(4-氯苯基)苯基亚甲基]-2,3-二氢-2-氧代-1H-吲哚-1-基]甲基]苯甲酸 |
1273323-67-3 |
| 3-((N)-1-(2-Nitrophenyl)ethylcarboxy)-(2-Aminoethyl)-1H-indol-5-ol |
3-((N)-1-(2-Nitrophenyl)ethylcarboxy)-(2-Aminoethyl)-1H-indol-5-ol |
1257326-22-9 |
| Termitomycamide B |
Termitomycamide B |
1254277-89-8 |
| GSK-2269557 |
GSK2269557 |
1254036-77-5 |
| (1R,2R)-N-([S]-1-{4-[5-broMo-2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxaMide |
(1R,2R)-N-([S]-1-{4-[5-BROMO-2-OXO-2,3-DIHYDRO-1H-BENZO(D)IMIDAZOL-1-YL]PIPERIDIN-1-YL}PROPAN-2-YL)-2-PHENYLCYCLOPROPANECARBOXAMIDE;VU0359595 |
1246303-14-9 |
| RN486 |
RN 486 |
1242156-23-5 |
| CPI 360 |
1802175-06-9 |
1802175-06-9 |
| Salicylcurcumin |
Salicylcurcumin |
1236545-54-2 |
| CAY10650 |
CAY10650 |
1233706-88-1 |
| VU0483605 |
VU0483605 |
1623101-11-0 |
| UNC 2400 |
UNC 2400 |
1433200-49-7 |
